Incidence and survival of patients with conjunctival melanoma in Europe
JAMA Ophthalmology Jun 15, 2020
Virgili G, Parravano M, Gatta G, et al. - The incidence and survival of patients with conjunctival melanoma in Europe were determined via performing a cohort study of 724 patients (512 [70.7%]: 55 years or older; 366 [50.6%] were female) with conjunctival melanoma from population-based data of 41 cancer registries. Observations revealed the overall incidence of 0.46 cases per 1,000,000 person-years. Overall, 5-year relative survival of 83.5% was noted; European geographic areas differed in the 5-year relative survival, with the highest in the UK and Ireland (89.1%) and lowest in Southern Europe (65.7%). This study presents the first Europe-wide estimates of the incidence and relative survival of patients with CM utilizing population-based data. Geographical disparities in survival suggest room for outcome improvement in Southern, Northern, and Eastern European countries.
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries